Status:
COMPLETED
Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Conditions:
Hyperventilation Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it ...
Eligibility Criteria
Inclusion
- Positive hyperventilation syndrome diagnosis
- Having a social security insurance
- Being at least 18 years old
- Having given their written consent
Exclusion
- Being put under guardianship or curatorship
- Having seen a physiotherapist for a respiratory rehabilitation in the last three months
- Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, …)
- Not being able to receive the respiratory rehabilitation from our care providers
- Already having received a rehabilitation for hyperventilation syndrome
- Not speaking French or not being unable to complete the questionnaires
Key Trial Info
Start Date :
March 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04668638
Start Date
March 10 2021
End Date
July 1 2025
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR d'Orléans
Orléans, France